Chugai Pharmaceutical Takes Significant Step by Acquiring Renalys Pharma Chugai Pharmaceutical has announced its strategic acquisition of Renalys Pharma, enhancing its capabilities in chronic kidney disease treatments across Asia.

Chugai Pharmaceutical Takes Significant Step by Acquiring Renalys Pharma #Japan #Tokyo #Sparsentan #Renalys_Pharma #Chugai_Pharmaceutical

Shellpa Launches SmartESG to Support Chugai Pharmaceutical's Sustainability Disclosure Shellpa & Company has initiated the provision of SmartESG, a cloud service aiding Chugai Pharmaceutical in sustainability information disclosure, effective August 2025.

Shellpa Launches SmartESG to Support Chugai Pharmaceutical's Sustainability Disclosure #Japan #Tokyo #SmartESG #Chugai_Pharmaceutical #Shellpa_Company

LTS Completes Support for BPM Promotion at Chugai Pharmaceutical's Business Transformation Division LTS has successfully completed its BPM support for Chugai Pharmaceutical's Business Transformation Division, enhancing their overall business processes.

LTS Completes Support for BPM Promotion at Chugai Pharmaceutical's Business Transformation Division #Japan #Tokyo #Business_Process #Chugai_Pharmaceutical #LTS